174 related articles for article (PubMed ID: 37917619)
21. Multiplex ligation-dependent probe amplification versus fluorescent in situ hybridization for screening
Eid OM; El Zomor H; Mohamed AM; El-Bassyouni HT; Afifi HH; El-Ayadi M; Sadek SH; Hammad SA; Salem SI; Mahrous R; Fadel IM; Refaat K; Afifi MA; Shelil AE; Ziko OAO; Abdel Azeem AA; El-Haddad A
Ophthalmic Genet; 2022 Dec; 43(6):789-794. PubMed ID: 36098066
[TBL] [Abstract][Full Text] [Related]
22.
Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
[No Abstract] [Full Text] [Related]
23. RB1 gene mutations and genetic spectrum in retinoblastoma cases.
Akdeniz Odemis D; Kebudi R; Bayramova J; Kilic Erciyas S; Kuru Turkcan G; Tuncer SB; Sukruoglu Erdogan O; Celik B; Kurt Gultaslar B; Buyukkapu Bay S; Tuncer S; Yazici H
Medicine (Baltimore); 2023 Sep; 102(36):e35068. PubMed ID: 37682130
[TBL] [Abstract][Full Text] [Related]
24. A c.1363C>T (p.R455X) nonsense mutation of RB1 gene in a southern Chinese retinoblastoma pedigree.
Chen CY; Xu CM; Du ZF; Chen XL; Ren GL; Zhang XN
Genet Test Mol Biomarkers; 2010 Apr; 14(2):193-6. PubMed ID: 20059380
[TBL] [Abstract][Full Text] [Related]
25. Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine.
Palomar-Siles M; Heldin A; Zhang M; Strandgren C; Yurevych V; van Dinter JT; Engels SAG; Hofman DA; Öhlin S; Meineke B; Bykov VJN; van Heesch S; Wiman KG
Cell Death Dis; 2022 Nov; 13(11):997. PubMed ID: 36433934
[TBL] [Abstract][Full Text] [Related]
26. Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant
Heldin A; Cancer M; Palomar-Siles M; Öhlin S; Zhang M; Sun-Zhang A; Mariani A; Liu J; Bykov VJN; Wiman KG
RNA Biol; 2023 Jan; 20(1):368-383. PubMed ID: 37339263
[TBL] [Abstract][Full Text] [Related]
27. Molecular alterations in retinoblastoma beyond RB1.
Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
[TBL] [Abstract][Full Text] [Related]
28. RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling.
Parma D; Ferrer M; Luce L; Giliberto F; Szijan I
PLoS One; 2017; 12(12):e0189736. PubMed ID: 29261756
[TBL] [Abstract][Full Text] [Related]
29. Novel insights into RB1 mutation.
Yao Y; Gu X; Xu X; Ge S; Jia R
Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
[TBL] [Abstract][Full Text] [Related]
30. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
[TBL] [Abstract][Full Text] [Related]
31. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
[TBL] [Abstract][Full Text] [Related]
32. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database.
Valverde JR; Alonso J; Palacios I; Pestaña A
BMC Genet; 2005 Nov; 6():53. PubMed ID: 16269091
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive, sensitive and economical approach for the detection of mutations in the RB1 gene in retinoblastoma.
Parsam VL; Kannabiran C; Honavar S; Vemuganti GK; Ali MJ
J Genet; 2009 Dec; 88(4):517-27. PubMed ID: 20090211
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel RB1 genetic variants in Retinoblastoma patients and their impact on clinical outcome.
Manukonda R; Pujar A; Ramappa G; Vemuganti GK; Kaliki S
Ophthalmic Genet; 2022 Feb; 43(1):64-72. PubMed ID: 34645364
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of disease phenotype through alternative translation initiation in low-penetrance retinoblastoma.
Sánchez-Sánchez F; Ramírez-Castillejo C; Weekes DB; Beneyto M; Prieto F; Nájera C; Mittnacht S
Hum Mutat; 2007 Feb; 28(2):159-67. PubMed ID: 16988938
[TBL] [Abstract][Full Text] [Related]
36. Germline
Le Gall J; Dehainault C; Boutte M; Petitalot A; Caputo SM; Courtois L; Vacher S; Bieche I; Radvanyi F; Pacquement H; Doz F; Lumbroso-Le Rouic L; Gauthier Villars M; Stoppa-Lyonnet D; Lallemand F; Houdayer C; Golmard L
J Med Genet; 2023 Dec; 61(1):78-83. PubMed ID: 37541786
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma.
Racher H; Soliman S; Argiropoulos B; Chan HS; Gallie BL; Perrier R; Matevski D; Rushlow D; Piovesan B; Shaikh F; MacDonald H; Corson TW
Cancer Genet; 2016; 209(7-8):359-63. PubMed ID: 27318443
[TBL] [Abstract][Full Text] [Related]
38. Linkage analysis and detection of somatic, postzygous RB1 mutations in Serbian retinoblastoma patients.
Kontic M; Palacios I; Kontic M; Alonso J; Pestana A
J BUON; 2011; 16(1):142-6. PubMed ID: 21674866
[TBL] [Abstract][Full Text] [Related]
39. [Molecular study of retinoblastoma in the Algerian population. Screening of Rb gene in constitutional and tumoral level].
Boubekeur A; Louhibi L; Mahmoudi K; Boudjema A; Mehtar N
Bull Cancer; 2012 Feb; 99(2):127-35. PubMed ID: 22265791
[TBL] [Abstract][Full Text] [Related]
40. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.
Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
